Advertisement

Imaging Correlation

  • Marie-Pierre Vullierme
  • Enrico Martone

Abstract

Ultrasonography (US), multidetector computed tomography (MDCT) and magnetic resonance imaging (MRI) often represent complementary imaging modalities, covering different roles in diagnosing focal or diffuse disease. US is an increasingly powerful imaging technique especially after intravenous injection of contrast agent for lesion characterization or with endoscopic approach for lesion detection. MDCT is still the modality of choice in studying solid tumors, and is mandatory for achieving adequate preoperative staging. On the other hand, MRI is the criterion standard for accurately evaluating both the ductal system and cystic lesions. Therefore, US and contrast-enhanced US (CEUS) could be seen to be at the center in choosing between MDCT and MRI, if a lesion is detected especially given that US is very often the first-line examination. This chapter provides a diagnostic algorithm based on US findings, and also discusses both the advantages and disadvantages of the US study compared to the other imaging modalities.

Keywords

Chronic Pancreatitis Cystic Lesion Main Pancreatic Duct Intraductal Papillary Mucinous Neoplasm Pancreatic Lesion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Prokesch RW, Chow LC, Beaulieu CF et al (2002) Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs. Radiology 224:764–768PubMedCrossRefGoogle Scholar
  2. 2.
    D’Onofrio M, Gallotti A, Pozzi Mucelli R (2010) Imaging techniques in pancreatic tumors. Expert Rev Med Devices 7:257–273PubMedCrossRefGoogle Scholar
  3. 3.
    Oshikawa O, Tanaka S, Ioka T et al (2002) Dynamic sonography of pancreatic tumors: comparison with dynamic CT. Am J Roentgenol 178:1133–1137Google Scholar
  4. 4.
    Martínez-Noguera A, D’Onofrio M (2007) Ultrasonography of the pancreas. 1. Conventional imaging. Abdom Imaging 32:136–149PubMedCrossRefGoogle Scholar
  5. 5.
    Shapiro RS, Wagreich J, Parsons RB et al (1998) Tissue harmonic imaging sonography: evaluation of image quality compared with conventional sonography. Am J Roentgenol 171:1203–1206Google Scholar
  6. 6.
    Hohl C, Schmidt T, Honnef D et al (2007) Ultrasonography of the pancreas. 2. Harmonic imaging. Abdom Imaging 32:150–160. ReviewPubMedCrossRefGoogle Scholar
  7. 7.
    Minniti S, Bruno C, Biasiutti C et al (2003) Sonography versus helical CT in identification and staging of pancreatic ductal adenocarcinoma. J Clin Ultrasound 31:175–182PubMedCrossRefGoogle Scholar
  8. 8.
    D’Onofrio M, Zamboni G, Faccioli N et al (2007) Ultrasonography of the pancreas. 4. Contrast-enhanced imaging. Abdom Imaging 32:171–181PubMedCrossRefGoogle Scholar
  9. 9.
    Bertolotto M, D’Onofrio M, Martone E et al (2007) Ultrasonography of the pancreas. 3. Doppler imaging. Abdom Imaging 32:161–170PubMedCrossRefGoogle Scholar
  10. 10.
    D’Onofrio M, Mansueto GC, Falconi M et al (2004) Neuroendocrine pancreatic tumor: value of contrast enhanced ultrasonography. Abdom Imaging 29:246–258PubMedCrossRefGoogle Scholar
  11. 11.
    D’Onofrio M, Malagò R, Zamboni G et al Contrast-enhanced ultrasonography better identifies pancreatic tumor vascularization than helical CT. Pancreatology 5:398–402Google Scholar
  12. 12.
    D’Onofrio M, Zamboni G, Malagò R et al (2009) Resectable pancreatic adenocarcinoma, is the enhancement pattern at contrast-enhanced ultrasonography a pre-operative prognostic factor? Ultrasound Med Biol 35:1929–1937PubMedCrossRefGoogle Scholar
  13. 13.
    Takeda K, Goto H, Hirooka Y et al (2003) Contrast-enhanced transabdominal ultrasonography in the diagnosis of pancreatic mass lesions. Acta Radiol 44:103–106PubMedCrossRefGoogle Scholar
  14. 14.
    D’Onofrio M, Martone E, Faccioli N et al (2006) Focal liver lesions, sinusoidal phase of CEUS. Abdom Imaging 31:529–536PubMedCrossRefGoogle Scholar
  15. 15.
    D’Onofrio M, Megibow AJ, Faccioli N et al (2007) Comparison of contrast-enhanced sonography and MRI in displaying anatomic features of cystic pancreatic masses. Am J Roentgenol 189:1435–1442CrossRefGoogle Scholar
  16. 16.
    Claudon M, Cosgrove D, Albrecht T et al (2008) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) — update. Ultraschall Med 29:28–44PubMedCrossRefGoogle Scholar
  17. 17.
    Numata K, Ozawa Y, Kobayashi N et al (2005) Contrast-enhanced sonography of pancreatic carcinoma, correlation with pathological findings. J Gastroenterol 40:631–640PubMedCrossRefGoogle Scholar
  18. 18.
    Sofuni A, Iijima H, Moriyasu F et al (2005) Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. J Gastroenterol 40:518–525PubMedCrossRefGoogle Scholar
  19. 19.
    Nagase M, Furuse J, Ishii H et al (2003) Evaluation of contrast enhancement patterns in pancreatic tumors by coded harmonic sonographic imaging with a microbubble contrast agent. J Ultrasound Med 22:789–795PubMedGoogle Scholar
  20. 20.
    D’Onofrio M, Zamboni G, Tognolini A et al (2006) Massforming pancreatitis: value of contrast-enhanced ultrasonography. World J Gastroenterol 12:4181–4184PubMedGoogle Scholar
  21. 21.
    Kitano M, Kudo M, Maekawa K et al (2004) Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut 53:854–859PubMedCrossRefGoogle Scholar
  22. 22.
    Hocke M, Schmidt C, Zimmer B et al (2008) Contrast enhanced endosonography for improving differential diagnosis between chronic pancreatitis and pancreatic cancer. Dtsch Med Wochenschr 133:1888–1892PubMedCrossRefGoogle Scholar
  23. 23.
    D’Onofrio M, Barbi E, Dietrich CF et al (2011) Pancreatic multicenter ultrasound study (PAMUS). Eur J Radiol doi:10.1016/j.ejrad.2011.01.053Google Scholar
  24. 24.
    Zamboni GA, D’Onofrio M, Idili A et al (2009) Ultrasoundguided percutaneous fine-needle aspiration of 545 focal pancreatic lesions. Am J Roentgenol 193:1691–1695CrossRefGoogle Scholar
  25. 25.
    Schima W, Ba-Ssalamah A, Kölblinger C et al (2007) Pancreatic adenocarcinoma. Eur Radiol 17:638–649PubMedCrossRefGoogle Scholar
  26. 26.
    Procacci C, Biasiutti C, Carbognin G et al (2001) Pancreatic neoplasms and tumor-like conditions. Eur Radiol 11[Suppl 2]:S167–S192Google Scholar
  27. 27.
    Sahani DV, Shah ZK, Catalano OA et al (2008) Radiology of pancreatic adenocarcinoma, current status of imaging. J Gastroenterol Hepatol 23:23–33PubMedCrossRefGoogle Scholar
  28. 28.
    Park HS, Lee JM, Choi HK et al (2009) Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT. J Magn Reson Imaging 30:586–595PubMedCrossRefGoogle Scholar
  29. 29.
    Kartalis N, Lindholm TL, Aspelin P et al (2009) Diffusion-weighted magnetic resonance imaging of pancreas tumours. Eur Radiol 19:1981–1990PubMedCrossRefGoogle Scholar
  30. 30.
    Miller FH, Rini NJ, Keppke AL (2006) MRI of adenocarcinoma of the pancreas. Am J Roentgenol 187:365–374CrossRefGoogle Scholar
  31. 31.
    Malagò R, D’Onofrio M, Zamboni GA et al (2009) Contrast-enhanced sonography of nonfunctioning pancreatic neuroendocrine tumors. Am J Roentgenol 192:424–430CrossRefGoogle Scholar
  32. 32.
    Procacci C, Carbognin G, Accordini S et al (2001) Nonfunctioning endocrine tumors of the pancreas: possibilities of spiral CT characterization. Eur Radiol 11:1175–1183PubMedCrossRefGoogle Scholar
  33. 33.
    D’Assignies G, Couvelard A, Bahrami S et al (2009) Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 250:407–416PubMedCrossRefGoogle Scholar
  34. 34.
    Kamisawa T, Takuma K, Anjiki H et al (2010) Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI. Am J Gastroenterol 105:1870–1875PubMedCrossRefGoogle Scholar
  35. 35.
    Ichikawa T, Sou H, Araki T et al (2001) Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 221:107–116PubMedCrossRefGoogle Scholar
  36. 36.
    Song SJ, Lee JM, Kim YJ et al (2007) Differentiation of intraductal papillary mucinous neoplasms from other pancreatic cystic masses: comparison of multirow-detector CT and MR imaging using ROC analysis. Magn Reson Imaging 26:86–93CrossRefGoogle Scholar
  37. 37.
    Yoon LS, Catalano OA, Fritz S et al (2009) Another dimension in magnetic resonance cholangiopancreatography: comparison of 2-and 3-dimensional magnetic resonance cholangiopancreatography for the evaluation of intraductal papillary mucinous neoplasm of the pancreas. J Comput Assist Tomogr 33:363–368PubMedCrossRefGoogle Scholar
  38. 38.
    Choi JY, Lee JM, Lee MW et al (2009) Magnetic resonance pancreatography: comparison of two-and three-dimensional sequences for assessment of intraductal papillary mucinous neoplasm of the pancreas Eur Radiol 19:2163–2170PubMedCrossRefGoogle Scholar
  39. 39.
    Sainani NI, Saokar A, Deshpande V et al (2009) Comparative performance of MDCT and MRI with MR cholangiopancreatography in characterizing small pancreatic cysts. Am J Roentgenol 193:722–731CrossRefGoogle Scholar
  40. 40.
    Waters JA, Schmidt CM, Pinchot JW et al (2008) CT vs MRCP: optimal classification of IPMN type and extent. J Gastrointest Surg 12:101–109PubMedCrossRefGoogle Scholar
  41. 41.
    Rickes S, Wermke W (2004) Differentiation of cystic pancreatic neoplasms and pseudocysts by conventional and echoenhanced ultrasound. J Gastroenterol Hepatol 19:761–766PubMedCrossRefGoogle Scholar
  42. 42.
    Masaki T, Ohkawa S, Amano A et al (2005) Noninvasive assessment of tumor vascularity by contrast-enhanced ultrasonography and the prognosis of patients with nonresectable pancreatic carcinoma. Cancer 103:1026–1035PubMedCrossRefGoogle Scholar
  43. 43.
    Tawada K, Yamaguchi T, Kobayashi A et al (2009) Changes in tumor vascularity depicted by contrast-enhanced ultrasonography as a predictor of chemotherapeutic effect in patients with unresectable pancreatic cancer. Pancreas 38:30–35PubMedCrossRefGoogle Scholar
  44. 44.
    Kobayashi A, Yamaguchi T, Ishihara T et al (2005) Evaluation of vascular signal in pancreatic ductal carcinoma using contrast enhanced ultrasonography: effect of systemic chemotherapy. Gut 54:1047PubMedCrossRefGoogle Scholar
  45. 45.
    Schmidt CM, White PB, Waters JA et al (2007) Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg 246:644–651PubMedCrossRefGoogle Scholar
  46. 46.
    Manfredi R, Graziani R, Motton M et al (2009) Main pancreatic duct intraductal papillary mucinous neoplasms: accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis. Radiology 253:106–115PubMedCrossRefGoogle Scholar
  47. 47.
    Inan N, Arslan A, Akansel G et al (2008) Diffusion-weighted imaging in the differential diagnosis of cystic lesions of the pancreas. Am J Roentgenol 191:1115–1121CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  1. 1.Department of RadiologyBeaujon HospitalClichy, ParisFrance
  2. 2.Department of RadiologyG.B. Rossi University HospitalVeronaItaly

Personalised recommendations